anmelden
OMX Copenhagen 20
1.544,40
PKT
+5,93
PKT
+0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen 20-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.04.16 | Novo Nordisk overweight | Morgan Stanley | |
| 18.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.04.16 | Novo Nordisk Hold | Deutsche Bank AG | |
| 29.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 15.03.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 07.03.16 | Novo Nordisk Sell | UBS AG | |
| 07.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 07.03.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 24.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.02.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 16.02.16 | Novo Nordisk Neutral | BNP PARIBAS | |
| 15.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.02.16 | Novo Nordisk Halten | Independent Research GmbH | |
| 08.02.16 | Novo Nordisk Sell | UBS AG | |
| 04.02.16 | Novo Nordisk overweight | Barclays Capital | |
| 04.02.16 | Novo Nordisk Neutral | UBS AG | |
| 04.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.02.16 | Novo Nordisk verkaufen | S&P Capital IQ | |
| 01.02.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.16 | Novo Nordisk buy | Citigroup Corp. | |
| 01.02.16 | Novo Nordisk overweight | Morgan Stanley | |
| 01.02.16 | Novo Nordisk Neutral | UBS AG | |
| 01.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.01.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 14.01.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 08.01.16 | Novo Nordisk overweight | Barclays Capital | |
| 07.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 06.01.16 | Novo Nordisk overweight | Morgan Stanley | |
| 10.12.15 | Novo Nordisk Neutral | BNP PARIBAS | |
| 02.12.15 | Novo Nordisk overweight | Morgan Stanley | |
| 01.12.15 | Novo Nordisk Halten | Independent Research GmbH | |
| 30.11.15 | Novo Nordisk Hold | Deutsche Bank AG | |
| 25.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 20.11.15 | Novo Nordisk Neutral | UBS AG |